EUVIMEDEUVIMED entdecken
Crossref

Association between COVID‐19 vaccination and atrial arrhythmias in individuals with cardiac implantable electronic devices

Abhishek J Deshmukh iD, Rimsha Ahmad, Yong-Mei Cha iD, Siva K Mulpuru iD, Christopher V DeSimone iD, Ammar M Killu iD, Steven Mullane, Camden Harrell, Valentina Kutyifa iD, Jim W Cheung iD, Gaurav A Upadhyay, Jonathan P Piccini iD und 2 weitere

Journal of Cardiovascular Electrophysiology · 2024

DOI: 10.1111/jce.16372 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cardiovascular Electrophysiology, 2024. Verfasst von Abhishek J Deshmukh und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: COVID-19 Vaccines, Defibrillators, Implantable, COVID-19, Vaccination. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The impact of mRNA‐based coronavirus disease‐2019 (COVID‐19) vaccines on atrial arrhythmias (AA) and ventricular arrhythmias incidence is unknown.

Methods

BIOTRONIK Home Monitoring data and Medicare Claims data were utilized to identify individuals implanted with a cardiac implantable electronic device (CIED) between 2010 and 2020 who received one or more doses of COVID‐19 vaccine in 2021. The burden of AA (%) in the 3 months postvaccination was compared to those noted in the preceding 3 months using the Wilcoxon signed rank test. Sub‐analyses comparing the effects of the influenza vaccine against the COVID‐19 vaccine were also evaluated for individuals who received the influenza vaccine in 2020. A 1:1 propensity score match comparison between COVID‐19 vaccine and non‐vaccinated patients was also performed.

Results

First and second doses of the COVID‐19 vaccine were administered to 7757 and 6579 individuals with a CIED (age 76.2 ± 9.0 years, 49% males), respectively. While a small but statistically significant increase in the burden of AA was noted in the 3 months postvaccination compared to the preceding 3 months after the first dose of the COVID‐19 vaccine (0.43 ± 9.04%, p = .028) a similar rise in AA was found following the influenza vaccine and for matched patients who did not receive the COVID‐19 vaccine. No significant difference in device therapies was seen pre‐ and postvaccination.

Conclusions

Though we report a small but significant increase in the number of CIED‐detected AAs following vaccination for COVID‐19 over a 3‐month window, we believe these results correlate more with time and the progressive nature of AF rather than the vaccine itself. While these data should not dissuade from the use of these vaccines, increased vigilance and prompt treatment of AF is required for high‐risk groups, specifically males over 70 years of age, following vaccination.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19 VaccinesDefibrillators, ImplantableCOVID-19VaccinationInfluenza VaccinesHumansMaleFemaleAgedAged, 80 and overUnited StatesTime FactorsRetrospective StudiesAtrial FibrillationRisk FactorsPacemaker, ArtificialIncidenceMedicareRisk AssessmentDatabases, FactualTreatment OutcomeArrhythmias, Cardiac

Stichwörter der Autor:innen

COVID‐19atrial arrhythmiaatrial fibrillationimplantable cardioverter defibrillatormRNApacemakervaccineventricular tachycardia

Substanzen

COVID-19 VaccinesInfluenza Vaccines

Autor:innen und Institutionen

  • Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA.
  • BIOTRONIK Inc., Lake Oswego, Oregon, USA.
  • Clinical Cardiovascular Research Center, University of Rochester, Rochester, New York, USA.
  • Division of Cardiology, Department of Medicine, Weill Cornell Medicine/New York-Presbyterian Hospital, New York, New York, USA.
  • The University of Chicago Medicine, Pritzker School of Medicine, Illinois, USA.
  • Duke Clinical Research Institute, Duke University, Durham, North Carolina, USA.

ORCID-Profile: Abhishek J Deshmukh, Yong-Mei Cha, Siva K Mulpuru, Christopher V DeSimone, Ammar M Killu, Valentina Kutyifa, Jim W Cheung, Jonathan P Piccini, Malini Madhavan

Zitieren

APA

Deshmukh, A. J., Ahmad, R., Cha, Y. M., Mulpuru, S. K., DeSimone, C. V., Killu, A. M., Mullane, S., Harrell, C., Kutyifa, V., Cheung, J. W., Upadhyay, G. A., Piccini, J. P., Hayes, D. L., & Madhavan, M. (2024). Association between COVID‐19 vaccination and atrial arrhythmias in individuals with cardiac implantable electronic devices. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/jce.16372

Vancouver

Deshmukh AJ, Ahmad R, Cha YM, Mulpuru SK, DeSimone CV, Killu AM, et al. Association between COVID‐19 vaccination and atrial arrhythmias in individuals with cardiac implantable electronic devices. Journal of Cardiovascular Electrophysiology. 2024. doi:10.1111/jce.16372

BibTeX
@article{Deshmukh2024,
  author = {Deshmukh, Abhishek J and Ahmad, Rimsha and Cha, Yong-Mei and Mulpuru, Siva K and DeSimone, Christopher V and Killu, Ammar M and Mullane, Steven and Harrell, Camden and Kutyifa, Valentina and Cheung, Jim W and Upadhyay, Gaurav A and Piccini, Jonathan P and Hayes, David L and Madhavan, Malini},
  title = {Association between COVID‐19 vaccination and atrial arrhythmias in individuals with cardiac implantable electronic devices},
  journal = {Journal of Cardiovascular Electrophysiology},
  year = {2024},
  doi = {10.1111/jce.16372}
}
Kostenlos starten →